Medtronic's most recent trend suggests a bearish bias. One trading opportunity on Medtronic is a Bear Call Spread using a strike $90.00 short call and a strike $95.00 long call offers a potential 50.15% return on risk over the next 17 calendar days. Maximum profit would be generated if the Bear Call Spread were to expire worthless, which would occur if the stock were below $90.00 by expiration. The full premium credit of $1.67 would be kept by the premium seller. The risk of $3.33 would be incurred if the stock rose above the $95.00 long call strike price.
The 5-day moving average is moving down which suggests that the short-term momentum for Medtronic is bearish and the probability of a decline in share price is higher if the stock starts trending.
The 20-day moving average is moving down which suggests that the medium-term momentum for Medtronic is bearish.
The RSI indicator is at 34.38 level which suggests that the stock is neither overbought nor oversold at this time.
To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here
LATEST NEWS for Medtronic
Medtronic (MDT) Dips More Than Broader Markets: What You Should Know
Fri, 28 Dec 2018 22:50:10 +0000
In the latest trading session, Medtronic (MDT) closed at $89.26, marking a -0.44% move from the previous day.
Will A New Approval Help This Medical Stock Approach A Breakout?
Fri, 28 Dec 2018 21:09:29 +0000
Edwards Lifesciences gained approval for a new transcatheter heart-valve replacement, or TAVR, system Friday — helping its stock to stay within a consolidation.
Medtronic Chairman and CEO Omar Ishrak to Speak at J.P. Morgan Healthcare Conference
Fri, 28 Dec 2018 14:01:00 +0000
December 28, 2018 – Medtronic plc (MDT), the global leader in medical technology, today announced it will participate in the 37th Annual J.P. Morgan Healthcare Conference in San Francisco. Omar Ishrak, Medtronic chairman and chief executive officer, will make a formal presentation on the company beginning at 9:00 a.m. PST (11:00 a.m. CST) on Monday, January 7, 2019. Shortly following the presentation, Ishrak and Karen Parkhill, executive vice president and chief financial officer, will answer questions on the company.
Medtronic's Growth Across All Lines Aid, Rising Costs Ail
Thu, 27 Dec 2018 21:52:09 +0000
Of late, Medtronic (MDT) succeeds in delivering solid top-line growth at CER, backed by balanced growth across major business operation.
Robots, DNA And Implantable Devices — Why 2019 Isn't Your Dad's Medtech
Thu, 27 Dec 2018 19:45:58 +0000
Innovation will continue in medical technology with a deeper influence from robotics, DNA sequencing and implantable devices, analysts say. Medtech stocks are expected to be strong in 2019.
Also on Market Tamer…
Follow Us on Facebook